Volume 19, Issue 60 (4-2025)
MLJ 2025, 19(60): 931-943 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kahi H R, Rezapoor B, Soleimanzadeh A R. Technical Responsibilities of Miners with Pharmaceutical Use in New Contracts of the Ministry of Health. MLJ 2025; 19 (60) :931-943
URL: http://ijmedicallaw.ir/article-1-2003-en.html
URL: http://ijmedicallaw.ir/article-1-2003-en.html
1- Department of Law, Urmia Branch, Islamic Azad University, Urmia, Iran.
Abstract:
Background and Aim: Investment in drug production lacks economic justification and drug import is also associated with challenges due to high costs and lack of adequate standards. At the request of the Ministry of Health, the Ministry of Health prepared a new model of contracts for the transfer of mines with medicinal use, which, in addition to granting some privileges to the miner, will be required to set up a holding company for the production of medicines with the final standards of the Ministry of Health. In this study, the technical responsibilities of miners in this field have been studied.
Method: This research was conducted using an analytical-descriptive method and attempted to legally analyze the new contract of the Ministry of Health.
Ethical Considerations: In all stages of writing, the research principles were followed.
Results: The nature and essence of medicinal minerals require that their processing be carried out directly within the country, because the export of the aforementioned raw materials creates corruption, loss of national wealth and the need to import medicines. Therefore, it is proposed that privileges such as a commitment to a maintenance contractor after the end of the exploitation period be granted in return for setting up a processing holding. These unprecedented rights and obligations cannot be contrary to the mandatory rules of law and therefore these types of contracts are included in indefinite and correct contracts.
Conclusion: The Ministry of Health's single-stage supervision of manufactured medicines lacks the necessary competence to identify molecular compounds, digestibility, and reactivity. Therefore, it is necessary to carry out supervision in three stages: mine registration, material extraction and final production of the medicine and this important matter should be included in the contract form. In this case, while preventing capital waste, side effects of the medicine can be identified and can meet the general concerns of this field.
Please cite this article as:
Kahi HR, Rezapoor B, Soleimanzadeh AR. Technical Responsibilities of Miners with Pharmaceutical Use in New Contracts of the Ministry of Health. Medical Law Journal. 2025; 19: e61.
Method: This research was conducted using an analytical-descriptive method and attempted to legally analyze the new contract of the Ministry of Health.
Ethical Considerations: In all stages of writing, the research principles were followed.
Results: The nature and essence of medicinal minerals require that their processing be carried out directly within the country, because the export of the aforementioned raw materials creates corruption, loss of national wealth and the need to import medicines. Therefore, it is proposed that privileges such as a commitment to a maintenance contractor after the end of the exploitation period be granted in return for setting up a processing holding. These unprecedented rights and obligations cannot be contrary to the mandatory rules of law and therefore these types of contracts are included in indefinite and correct contracts.
Conclusion: The Ministry of Health's single-stage supervision of manufactured medicines lacks the necessary competence to identify molecular compounds, digestibility, and reactivity. Therefore, it is necessary to carry out supervision in three stages: mine registration, material extraction and final production of the medicine and this important matter should be included in the contract form. In this case, while preventing capital waste, side effects of the medicine can be identified and can meet the general concerns of this field.
Please cite this article as:
Kahi HR, Rezapoor B, Soleimanzadeh AR. Technical Responsibilities of Miners with Pharmaceutical Use in New Contracts of the Ministry of Health. Medical Law Journal. 2025; 19: e61.
Type of Study: Original Article |
Received: 2025/07/16 | Accepted: 2025/10/25
Received: 2025/07/16 | Accepted: 2025/10/25
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
